Ann Flynn
( out of 114 reviews )

Ann Flynn, MD

Languages spoken: English

Clinical Locations

South Jordan Health Center

South Jordan
801-213-4500
Directions

Gastroenterology /GI Clinic UUH

Gastroenterology, Area E
Salt Lake City
801-213-9797
Directions

  • Dr. Flynn attended medical school at New York Medical College. She completed internal medicine residency training at the University of Colorado School of Medicine and gastroenterology fellowship training at the Indiana University School of Medicine. She completed an advanced fellowship in inflammatory bowel disease at Indiana University. Her clinical interests include diagnosis and management of inflammatory diseases of the GI tract including Crohn's disease, ulcerative colitis, and microscopic colitis. She is passionate about women's GI health, shared decision-making discussions, patient education, personalized care for patients with inflammatory bowel disease, and assisting patients transitioning care from pediatric to adult GI clinics. Dr. Flynn is a member of the American College of Gastroenterology Patient Care Committee and the Crohn's and Colitis Foundation Patient Education Committee. She currently serves as the American College of Gastroenterology Governor for Utah.

    The University of Utah Inflammatory Bowel Disease Program is a participating site in IBD Qorus, a collaboration between patients and healthcare providers to improve the quality of IBD care across the country, to ensure all patients receive the highest quality IBD care, treatment, and disease outcomes. Dr. Flynn serves as the IBD Qorus physician leader for the University of Utah.

    Dr. Flynn is board certified in Gastroenterology. She is a member of the American College of Gastroenterology, the American Gastroenterological Association, the American Society for Gastrointestinal Endoscopy, and the Crohn’s and Colitis Foundation.

    Specialties

    Board Certification

    American Board of Internal Medicine (Sub: Gastroenterology)

    Patient Rating

    4.9 /5
    ( out of 114 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    January 14, 2025
    UNIVERSITY HOSPITAL

    All I can say is Ann is fantastic!!!

    January 10, 2025
    UNIVERSITY HOSPITAL

    Ann Debourcy Flynn's kind, conscientious attention to my health and wellbeing and Ann's kind, informative conversation along with her precious, welcoming smile always are of inestimable value and meaaningful consequence to me. Ann's precious, welcoming smile, brilliant conscientiousness and caring heart are each a crucial part of her magnificent healing art. [NAME REMOVED]

    January 08, 2025
    UNIVERSITY HOSPITAL

    I love Dr. Flynn! She's takes such great care of me and always listens carefully and answers all my questions.

    December 18, 2024
    UH HOSPITALS AND CLINICS

    They were very good [TRANSLATED]

    December 13, 2024
    UH HOSPITALS AND CLINICS

    Dr Flynn is great, she is very knowledgeable and works with you to find a solution for treatment. She is always willing to listen and she will always try to direct your care in a way that you both agree is the right path.

    December 06, 2024
    UH HOSPITALS AND CLINICS

    She is very thorough and has a wonderful sense of humor!

    November 06, 2024
    UH HOSPITALS AND CLINICS

    Dr. Flynn is patient and has great bedside manner

    October 02, 2024
    UH HOSPITALS AND CLINICS

    Dr Flynn has been amazing at providing care and being very professional.

    September 24, 2024
    UH HOSPITALS AND CLINICS

    Dr Flynn really cares about her patient's. She has worked to find solutions for my issues and has helped me get my life back!

  • Dr. Flynn attended medical school at New York Medical College. She completed internal medicine residency training at the University of Colorado School of Medicine and gastroenterology fellowship training at the Indiana University School of Medicine. She completed an advanced fellowship in inflammatory bowel disease at Indiana University. Her clinical interests include diagnosis and management of inflammatory diseases of the GI tract including Crohn's disease, ulcerative colitis, and microscopic colitis. She is passionate about women's GI health, shared decision-making discussions, patient education, personalized care for patients with inflammatory bowel disease, and assisting patients transitioning care from pediatric to adult GI clinics. Dr. Flynn is a member of the American College of Gastroenterology Patient Care Committee and the Crohn's and Colitis Foundation Patient Education Committee. She currently serves as the American College of Gastroenterology Governor for Utah.

    The University of Utah Inflammatory Bowel Disease Program is a participating site in IBD Qorus, a collaboration between patients and healthcare providers to improve the quality of IBD care across the country, to ensure all patients receive the highest quality IBD care, treatment, and disease outcomes. Dr. Flynn serves as the IBD Qorus physician leader for the University of Utah.

    Dr. Flynn is board certified in Gastroenterology. She is a member of the American College of Gastroenterology, the American Gastroenterological Association, the American Society for Gastrointestinal Endoscopy, and the Crohn’s and Colitis Foundation.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Associate Professor (Clinical)
    Academic Divisions Gastroenterology
    Board Certification
    American Board of Internal Medicine (Sub: Gastroenterology)

    Education history

    Fellowship Inflammatory Bowel Disease - Indiana University Advanced Fellow
    Fellowship Gastroenterology and Hepatology - Indiana University Chief Fellow
    Fellowship Gastroenterology and Hepatology - Indiana University Fellow
    Residency Internal Medicine - University of Colorado at Denver Resident
    Internship Internal Medicine - University of Colorado at Denver Intern
    Professional Medical Alpha Omega Alpha - New York Medical College M.D.
    Undergraduate Molecular Biology, Senior Thesis: Identification of Genes Involved in Fab-7 boundary function by F2 EMS Mutagenesis Screen. - Princeton University A.B.

    Selected Publications

    Journal Article

    1. Levic DS, Niedzwiecki D, Kandakatla A, Karlovich NS, Juneja A, Park J, Stolarchuk C, Adams S, Willer JR, Schaner MR, Lian G, Beasley C, Marjoram L, Flynn AD, Valentine JF, Onken JE, Sheikh SZ, Davis EE, Evason KJ, Garman KS, Bagnat M (2024). TNF promoter hypomethylation is associated with mucosal inflammation in IBD and anti-TNF response.  medRxiv (preprint)  2024 Feb 6:2024. medRxiv.
    2. Pozdnyakova V, Botwin GJ, Sobhani K, Prostko J, Braun J, Mcgovern DPB, Melmed GY, Appel K, Banty A, Feldman E, Ha C, Kumar R, Lee S, Rabizadeh S, Stein T, Syal G, Targan S, Vasiliauskas E, Ziring D, Debbas P, Hampton M, Mengesha E, Stewart JL, Frias EC, Cheng S, Ebinger J, Figueiredo JC, Boland B, Charabaty A, Chiorean M, Cohen E, Flynn A, Valentine J, Fudman D, Horizon A, Hou J, Hwang C, Lazarev M, Lum D, Fausel R, Reddy S, Mattar M, Metwally M, Ostrov A, Parekh N, Raffals L, Sheibani S, Siegel C, Wolf D, Younes Z (2021). Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel Disease. Gastroenterology, 161(6), 2041-2043.e1. (Read full article)
    3. Almario CV, Kogan L, van Deen WK, Scott FI, Singh S, Hou JK, Lum D, Aguilar H, Betteridge J, Flynn A, Gerich M, Kaufman L, Mattar MC, Mize C, Ostrov A, Shah SA, Younes Z, Weaver SA, Heller C, Siegel CA, Melmed GY (2021). Health Economic Impact of a Multicenter Quality-of-Care Initiative for Reducing Unplanned Healthcare Utilization Among Patients With Inflammatory Bowel Disease. Am J Gastroenterol, 116(12), 2459-2464. (Read full article)
    4. Lewis JD, Sandler R, Brotherton C, Brensinger C, Li H, Kappelman MD, Daniel SG, Bittinger K, Albenberg L, Valentine JF, Hanson J, Suskind D, Meyer A, Compher CW, Bewtra M, Saxena A, Dobes A, Cohen B, Flynn AD, Fischer M, Saha S, Swaminath A, Yacyshyn B, Scherl E, Horst S, Curtis JR, Braly K, Nessel L, McCauley M, McKeever L, Herfarth H, DINE-CD Study Group (2021). A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults with Crohn's Disease. Gastroenterology, 161, 837-852.e9. (Read full article)
    5. Cheng YW, Phelps E, Ganapini V, Khan N, Ouyang F, Xu H, Khanna S, Tariq R, Friedman-Moraco RJ, Woodworth MH, Dhere T, Kraft CS, Kao D, Smith J, Le L, El-Nachef N, Kaur N, Kowsika S, Ehrlich A, Smith M, Safdar N, Misch EA, Allegretti JR, Flynn A, Kassam Z, Sharfuddin A, Vuppalanchi R, Fischer M (2018). Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience. Am J Transplant, 19(2), 501-511. (Read full article)
    6. DeBourcy AC, Lichtenberger S, Felton S, Butterfield KT, Ahnen DJ, Denberg TD (2008). Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med, 23(2), 169-74. (Read full article)

    Review

    1. Gawron LM, Sanders J, Steele K, Flynn A (2016). Reproductive Planning and Contraception for Women with Inflammatory Bowel Diseases. [Review]. Inflamm Bowel Dis, 22(2), 459-64.

    Abstract

    1. Melmed G, Hou JK, Lum D, Gerner D, Singh S, Crate DJ, Holthoff M, Kennedy AM, Aguilar H, Almario CV, Banty A, J Betteridge, Bhatti F, Bray H, Charabaty A, Dudley-Brown S, Fasanya-Uptagraft H, Fausel R, Fennimore B, Flynn AD, Gerich ME, Ghafari A, Ha C, Heagy E, Hudesman D, Hwang C, Kaufman L, Kaur N, Kim B, Mattar M, McCutcheon Adams K, Mehta F, Metwally M, Oliver BO, Ostrov A, Reddy S, Rubin DT, Scott FI, Shah S, Syal G, Valentine JF, van Deen WK, Vrabie R, Wang A, Williams E, Younes ZH, Yun L, Zisman T, Farraye FA, Nelson E, Heller C, Oberai R, Weaver A, Siegel CA (2020). Quality of Care Initiative Improves Outcomes for Patients with Inflammatory Bowel Disease.   [Abstract]. 158(6), S-8-S-9.
    2. Melmed G, Hou JK, Lum D, Gerner D, Singh S, Crate DJ, Holthoff M, Kennedy AM, Aguilar H, Almario CV, Banty A, J Betteridge, Bhatti F, Bray H, Charabaty A, Dudley-Brown S, Fasanya-Uptagraft H, Fausel R, Fennimore B, Flynn AD, Gerich ME, Ghafari A, Ha C, Heagy E, Hudesman D, Hwang C, Kaufman L, Kaur N, Kim B, Mattar M, McCutcheon Adams K, Mehta F, Metwally M, Oliver BO, Ostrov A, Reddy S, Rubin DT, Scott FI, Shah S, Syal G, Valentine JF, van Deen WK, Vrabie R, Wang A, Williams E, Younes ZH, Yun L, Zisman T, Farraye FA, Nelson E, Heller C, Oberai R, Weaver A, Siegel CA (2020). The IBD Urgent Care Toolkit: Which Process Changes are Associated with Successful Improvement? [Abstract]. 158(6), S-411.
    3. Melmed G, Hou JK, Lum D, Gerner D, Singh S, Crate DJ, Holthoff M, Kennedy AM, Aguilar H, Almario CV, Banty A, J Betteridge, Bhatti F, Bray H, Charabaty A, Dudley-Brown S, Fasanya-Uptagraft H, Fausel R, Fennimore B, Flynn AD, Gerich ME, Ghafari A, Ha C, Heagy E, Hudesman D, Hwang C, Kaufman L, Kaur N, Kim B, Mattar M, McCutcheon Adams K, Mehta F, Metwally M, Oliver BO, Ostrov A, Reddy S, Rubin DT, Scott FI, Shah S, Syal G, Valentine JF, van Deen WK, Vrabie R, Wang A, Williams E, Younes ZH, Yun L, Zisman T, Farraye FA, Nelson E, Heller C, Oberai R, Weaver A, Siegel CA (2020). Improvement in Inflammatory Bowel Disease Care Does Not Differ by Practice Type. [Abstract]. 158(6), S-412.
    4. Youngblood BA, Butuci M, Davis T, Xu A, Schanin J, Brock EC, Singh B, Rasmussen HS, Holman A, Drake R, Peterson K, Flynn AD (2020). Phenotypic Characterization of Inflammatory Bowel Disease Biopsies Reveal That Mast Cells Are Significantly Elevated and Activated In Patients with Ulcerative Colitis   [Abstract]. 26(Supplement 1), S33-34.

    Video/Film/CD/Web/Podcast

    1. Diet and Nutrition Initiative, Flynn A, Eichelberger K, Issokson K, Shah R, Yen E (2018). "IBD: Diet and Nutrition." Materials developed include webinar, animated videos, webpages, website, educational graphics, and an e-tool/game to provide patient education regarding malnutrition, food choices, nutritional support therapy, vitamin supplementation, and current research concerning diet and inflammatory bowel disease. Animated video topics include, "Malnutrition and IBD," "What to Eat when in a Flare," "What to Eat when in Remission," "Nutrition Support Therapy," and "Vitamin and Mineral Supplementation." A webinar on Complementary and Alternative Medicine for IBD is currently in development. [Web]. Crohn's and Colitis Foundation. Available: http://www.crohnscolitisfoundation.org/what-are-crohns-and-colitis/diet-and-nutrition/.
    2. Ausk K, Flynn A, Fennimore B (September 2016). Thinking about Colorectal Cancer. Understanding the Risks and Prevention. [Video]. Crohn's and Colitis Foundation of America. Available: https://youtu.be/uYCK7kZUbs8.